Safety, Tolerability and Pharmacokinetic Study of Recombinant Human Parathyroid Hormone rhPTH (1-84) in Chinese Healthy Volunteers
10.1007/s11596-009-0408-6
- Author:
LI QIAN
1
;
QIAO JIAN
;
DENG JUNGANG
;
ZENG TIANSHU
;
ZHOU PIQI
;
LI WEIYONG
Author Information
1. Institute of Clinical Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
- Keywords:
safety;
tolerability;
pharmacokinetics;
recombinant human parathyroid hormones
- From:
Journal of Huazhong University of Science and Technology (Medical Sciences)
2009;29(4):431-434
- CountryChina
- Language:Chinese
-
Abstract:
h. The parameters indicated the serum levels were directly proportional to the administered dose, with the mean Cmax and AUC0-24 ranging from approximately 543.47 to 1845 pg/mL and 2358.6 to 9232.12 mild and of short duration.
